172 related articles for article (PubMed ID: 29264150)
1. Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study.
Porcaro AB; Novella G; Balzarro M; Martignoni G; Brunelli M; Cacciamani G; Cerruto MA; Artibani W
Asian J Urol; 2015 Oct; 2(4):224-232. PubMed ID: 29264150
[TBL] [Abstract][Full Text] [Related]
2. Prostate volume index and chronic inflammation of the prostate type IV with respect to the risk of prostate cancer.
Porcaro AB; Novella G; Molinari A; Terrin A; Minja A; De Marco V; Martignoni G; Brunelli M; Cerruto MA; Curti P; Cavalleri S; Artibani W
Urol Int; 2015; 94(3):270-85. PubMed ID: 25170543
[TBL] [Abstract][Full Text] [Related]
3. Chronic Inflammation in Prostate Biopsy Cores is an Independent Factor that Lowers the Risk of Prostate Cancer Detection and is Inversely Associated with the Number of Positive Cores in Patients Elected to a First Biopsy.
Porcaro AB; Novella G; Mattevi D; Bizzotto L; Cacciamani G; Luyk ND; Tamanini I; Cerruto MA; Brunelli M; Artibani W
Curr Urol; 2016 May; 9(2):82-92. PubMed ID: 27390581
[TBL] [Abstract][Full Text] [Related]
4. Chronic inflammation of the prostate type IV with respect to risk of prostate cancer.
Porcaro AB; Rubilotta E; Petrozziello A; Ghimenton C; Migliorini F; Zecchini Antoniolli S; Lacola V; Monaco C; Curti P; Cavalleri S; Pianon R; Artibani W
Arch Ital Urol Androl; 2014 Sep; 86(3):208-11. PubMed ID: 25308586
[TBL] [Abstract][Full Text] [Related]
5. Intraprostatic chronic inflammation is associated with a reduced risk of prostate cancer in patients elected to a first random biopsy set.
Porcaro AB; Novella G; de Luyk N; Corsi P; Cacciamani G; Sebben M; Tafuri A; Processali T; Cerasuolo M; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Tumori; 2017 Sep; 103(5):475-482. PubMed ID: 27834470
[TBL] [Abstract][Full Text] [Related]
6. Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set.
Porcaro AB; Mattevi D; Novella G; De Luyk N; Corsi P; Bizzotto L; De Marchi D; Sebben M; Tafuri A; Inverardi D; Processali T; Cerruto MA; Brunelli M; Siracusano S; Artibani W
Curr Urol; 2018 Feb; 11(2):85-91. PubMed ID: 29593467
[TBL] [Abstract][Full Text] [Related]
7. Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml?
Xu N; Wu YP; Chen DN; Ke ZB; Cai H; Wei Y; Zheng QS; Huang JB; Li XD; Xue XY
J Cancer Res Clin Oncol; 2018 May; 144(5):987-995. PubMed ID: 29504080
[TBL] [Abstract][Full Text] [Related]
8. Atypical small acinar proliferation and two or more cores of high-grade intraepithelial neoplasia on a previous prostate biopsy are significant predictors of cancer during a transperineal template-guided saturation biopsy aimed at sampling one core for each 1 mL of prostate volume.
Nakai Y; Tanaka N; Miyake M; Hori S; Tatsumi Y; Morizawa Y; Fujii T; Konishi N; Fujimoto K
Res Rep Urol; 2017; 9():187-193. PubMed ID: 29034221
[TBL] [Abstract][Full Text] [Related]
9. "Finding the needle in a haystack": oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP).
Herlemann A; Wegner K; Roosen A; Buchner A; Weinhold P; Bachmann A; Stief CG; Gratzke C; Magistro G
World J Urol; 2017 Nov; 35(11):1777-1782. PubMed ID: 28516315
[TBL] [Abstract][Full Text] [Related]
10. Prostate-specific antigen (PSA) isoform p2PSA significantly improves the prediction of prostate cancer at initial extended prostate biopsies in patients with total PSA between 2.0 and 10 ng/ml: results of a prospective study in a clinical setting.
Guazzoni G; Nava L; Lazzeri M; Scattoni V; Lughezzani G; Maccagnano C; Dorigatti F; Ceriotti F; Pontillo M; Bini V; Freschi M; Montorsi F; Rigatti P
Eur Urol; 2011 Aug; 60(2):214-22. PubMed ID: 21482022
[TBL] [Abstract][Full Text] [Related]
11. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers.
Hoeks CM; Schouten MG; Bomers JG; Hoogendoorn SP; Hulsbergen-van de Kaa CA; Hambrock T; Vergunst H; Sedelaar JP; Fütterer JJ; Barentsz JO
Eur Urol; 2012 Nov; 62(5):902-9. PubMed ID: 22325447
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Proliferative Inflammatory Atrophy in Negative Prostatic Biopsies.
Servian P; Celma A; Planas J; Placer J; de Torres IM; Morote J
Prostate; 2016 Dec; 76(16):1501-1506. PubMed ID: 27404228
[TBL] [Abstract][Full Text] [Related]
13. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
[TBL] [Abstract][Full Text] [Related]
14. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
15. Association between obesity and frequency of high-grade prostate cancer on biopsy in men: A single-center retrospective study.
Baio R; Napodano G; Caruana C; Molisso G; Di Mauro U; Intilla O; Pane U; D'Angelo C; Francavilla AB; Guarnaccia C; Pentimalli F; Sanseverino R
Mol Clin Oncol; 2022 Aug; 17(2):127. PubMed ID: 35832470
[TBL] [Abstract][Full Text] [Related]
16. The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer.
Zheng S; Jiang S; Chen Z; Huang Z; Shi W; Liu B; Xu Y; Guo Y; Yang H; Li M
PLoS One; 2019; 14(11):e0218645. PubMed ID: 31743339
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
Kaufmann B; Saba K; Schmidli TS; Stutz S; Bissig L; Britschgi AJ; Schaeren E; Gu A; Langenegger N; Sulser T; Eberli D; Keller EX; Hermanns T; Poyet C
Prostate; 2022 Feb; 82(3):388-396. PubMed ID: 34914121
[TBL] [Abstract][Full Text] [Related]
18. Comparison of diagnostic efficacy between transrectal and transperineal prostate biopsy: A propensity score-matched study.
Jiang CY; Shen PF; Wang C; Gui HJ; Ruan Y; Zeng H; Xia SJ; Wei Q; Zhao FJ
Asian J Androl; 2019; 21(6):612-617. PubMed ID: 31006712
[TBL] [Abstract][Full Text] [Related]
19. High detection rate of significant prostate tumours in anterior zones using transperineal ultrasound-guided template saturation biopsy.
Mabjeesh NJ; Lidawi G; Chen J; German L; Matzkin H
BJU Int; 2012 Oct; 110(7):993-7. PubMed ID: 22394668
[TBL] [Abstract][Full Text] [Related]
20. Prostatic chronic inflammation and prostate cancer risk at baseline random biopsy: Analysis of predictors.
Tafuri A; Sebben M; Novella G; Pirozzi M; Processali T; Shakir A; Rizzetto R; Amigoni N; Bernasconi R; Brunelli M; Cerruto MA; Siracusano S; Antonelli A; Artibani W; Porcaro AB
Arab J Urol; 2020 May; 18(3):148-154. PubMed ID: 33029424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
